Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

West Pharmaceutical Services (WST)

West Pharmaceutical Services (WST)
203.42 +1.52 (+0.75%) 15:21 ET [NYSE]
203.22 x 4 203.57 x 1
Realtime by (Cboe BZX)
203.22 x 4 203.57 x 1
Realtime 200.71 -1.19 (-0.59%) 07:58 ET
Quote Overview for Mon, Apr 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
200.35
Day High
205.00
Open 205.00
Previous Close 201.90 201.90
Volume 437,068 437,068
Avg Vol 872,075 872,075
Stochastic %K 40.19% 40.19%
Weighted Alpha -34.89 -34.89
5-Day Change -6.66 (-3.16%) -6.66 (-3.16%)
52-Week Range 187.43 - 394.42 187.43 - 394.42
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 14,595,955
  • Shares Outstanding, K 72,293
  • Annual Sales, $ 2,893 M
  • Annual Income, $ 492,700 K
  • EBIT $ 570 M
  • EBITDA $ 725 M
  • 60-Month Beta 1.22
  • Price/Sales 5.23
  • Price/Cash Flow 23.21
  • Price/Book 5.65

Options Overview Details

View History
  • Implied Volatility 59.66% ( -1.12%)
  • Historical Volatility 42.23%
  • IV Percentile 96%
  • IV Rank 80.68%
  • IV High 68.27% on 04/07/25
  • IV Low 23.71% on 05/17/24
  • Put/Call Vol Ratio 0.07
  • Today's Volume 60
  • Volume Avg (30-Day) 331
  • Put/Call OI Ratio 0.70
  • Today's Open Interest 8,000
  • Open Int (30-Day) 9,906

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 1.30
  • Number of Estimates 5
  • High Estimate 1.59
  • Low Estimate 1.21
  • Prior Year 1.56
  • Growth Rate Est. (year over year) -16.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
187.43 +8.86%
on 04/09/25
Period Open: 228.68
234.02 -12.81%
on 03/24/25
-24.64 (-10.78%)
since 03/21/25
3-Month
187.43 +8.86%
on 04/09/25
Period Open: 344.69
348.90 -41.52%
on 01/28/25
-140.65 (-40.81%)
since 01/21/25
52-Week
187.43 +8.86%
on 04/09/25
Period Open: 372.04
394.42 -48.27%
on 04/24/24
-168.01 (-45.16%)
since 04/19/24

Most Recent Stories

More News
These 2 Dividend Aristocrats Are Top Stocks to Buy in Times of Uncertainty

These companies offer consistent dividend growth and a strong industry presence.

SPGI : 445.69 (-3.71%)
WST : 203.82 (+0.95%)
NOBL : 94.39 (-2.38%)
West Pharmaceutical Services Earnings Preview: What to Expect

West Pharmaceutical Services will release its first-quarter earnings later this month, and analysts anticipate a double-digit profit dip.

XLV : 131.92 (-2.63%)
$SPX : 5,112.79 (-3.22%)
WST : 203.82 (+0.95%)
3 Reasons to Sell WST and 1 Stock to Buy Instead

3 Reasons to Sell WST and 1 Stock to Buy Instead

KLAC : 612.26 (-3.49%)
WST : 203.82 (+0.95%)
3 S&P 500 Stocks That Concern Us

3 S&P 500 Stocks That Concern Us

HRL : 30.14 (-1.44%)
FOXA : 46.67 (-2.71%)
WST : 203.82 (+0.95%)
Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks

Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks

FTRE : 5.18 (-2.08%)
UFPT : 208.66 (-1.14%)
AZTA : 24.85 (-1.58%)
WST : 203.82 (+0.95%)
IQV : 139.92 (-2.77%)
Is West Pharmaceutical Services Stock Underperforming the S&P 500?

West Pharmaceutical Services has lagged behind the broader S&P 500 Index over the past year, but analysts remain highly optimistic about its future growth potential.

$SPX : 5,112.79 (-3.22%)
RMD : 210.26 (-1.24%)
WST : 203.82 (+0.95%)
Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE)

Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE)

FTRE : 5.18 (-2.08%)
MEDP : 287.79 (-2.87%)
AZTA : 24.85 (-1.58%)
WST : 203.82 (+0.95%)
IQV : 139.92 (-2.77%)
Unpacking Q4 Earnings: UFP Technologies (NASDAQ:UFPT) In The Context Of Other Drug Development Inputs & Services Stocks

Unpacking Q4 Earnings: UFP Technologies (NASDAQ:UFPT) In The Context Of Other Drug Development Inputs & Services Stocks

FTRE : 5.18 (-2.08%)
UFPT : 208.66 (-1.14%)
AZTA : 24.85 (-1.58%)
WST : 203.82 (+0.95%)
CRL : 101.65 (-4.15%)
3 Top-Rated Dividend Aristocrats to Buy Now for Passive Income

These three companies have increased their dividends for 25-plus years and offer a mix of stability, growth potential, and attractive yields.

KO : 72.23 (-1.05%)
$SPX : 5,112.79 (-3.22%)
SPGI : 445.69 (-3.71%)
WST : 203.82 (+0.95%)
Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks

Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks

FTRE : 5.18 (-2.08%)
UFPT : 208.66 (-1.14%)
AZTA : 24.85 (-1.58%)
RGEN : 130.12 (+0.09%)
WST : 203.82 (+0.95%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical...

See More

Key Turning Points

3rd Resistance Point 222.08
2nd Resistance Point 214.51
1st Resistance Point 208.20
Last Price 203.82
1st Support Level 194.32
2nd Support Level 186.75
3rd Support Level 180.44

See More

52-Week High 394.42
Fibonacci 61.8% 315.35
Fibonacci 50% 290.92
Fibonacci 38.2% 266.50
Last Price 203.82
52-Week Low 187.43

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro